Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATOS | TMO | ISRG | EW | IDXX |
| Company | Atossa Therapeutics Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Idexx Laboratories |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 1.6700 | 559.04 | 376.63 | 89.09 | 490.62 |
| High | 1.6899 | 559.04 | 376.63 | 89.16 | 493.61 |
| Low | 1.6300 | 558.27 | 375.05 | 89.04 | 490.52 |
| Last | 1.6750 | 555.15 | 371.79 | 88.04 | 488.94 |
| Change | -0.0350 | -2.72 | -5.57 | -1.16 | -2.35 |
| % Change | -2.05% | -0.49% | -1.48% | -1.30% | -0.48% |
| Volume | 57,253 | 17,985 | 35,185 | 26,521 | 5,973 |
| 20-Day Average Volume | 3,279,111 | 1,193,370 | 1,295,011 | 2,945,002 | 361,763 |
| Previous Close | 1.7100 | 557.87 | 377.36 | 89.20 | 491.29 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.7923 | 576.37 | 389.08 | 92.78 | 520.26 |
| 20-Day Raw Stochastic | 38.40% | 9.49% | 3.86% | 3.35% | 4.09% |
| 20-Day Relative Strength | 55.27% | 43.32% | 45.31% | 47.83% | 31.83% |
| Weighted Alpha | +117.34 | +1.87 | +27.87 | +9.93 | -1.98 |
| Today's Opinion | 88% Buy | 56% Buy | 56% Buy | 56% Buy | 24% Sell |
| Previous Opinion | 88% Buy | 64% Buy | 56% Buy | 56% Buy | 24% Sell |
| Last Month's Opinion | 88% Buy | 88% Buy | 100% Buy | 88% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.70% since 04/09/24 | -3.62% since 04/08/24 | -3.47% since 04/09/24 | -4.14% since 04/09/24 | -5.35% since 04/09/24 |
| Low | 1.5950 on 04/12/24 | 554.51 on 04/15/24 | 376.33 on 04/15/24 | 88.96 on 04/15/24 | 489.81 on 04/15/24 |
| High | 1.8400 on 04/11/24 | 589.93 on 04/09/24 | 392.80 on 04/11/24 | 92.99 on 04/11/24 | 512.72 on 04/10/24 |
| 1-Month | |||||
| %Chg | +30.23% since 03/15/24 | -4.50% since 03/15/24 | -4.77% since 03/15/24 | -3.37% since 03/15/24 | -7.13% since 03/15/24 |
| Low | 1.2400 on 03/18/24 | 554.51 on 04/15/24 | 376.33 on 04/15/24 | 88.96 on 04/15/24 | 489.81 on 04/15/24 |
| High | 2.3100 on 04/05/24 | 589.93 on 04/09/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 543.33 on 03/28/24 |
| 3-Month | |||||
| %Chg | +96.42% since 01/16/24 | +2.49% since 01/12/24 | +4.16% since 01/16/24 | +20.56% since 01/16/24 | -5.38% since 01/16/24 |
| Low | 0.7744 on 01/25/24 | 534.24 on 02/01/24 | 355.17 on 01/17/24 | 71.92 on 01/25/24 | 489.81 on 04/15/24 |
| High | 2.3100 on 04/05/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 583.39 on 03/01/24 |
| 6-Month | |||||
| %Chg | +150.00% since 10/16/23 | +15.54% since 10/13/23 | +37.65% since 10/16/23 | +25.16% since 10/16/23 | +14.54% since 10/16/23 |
| Low | 0.6200 on 11/13/23 | 415.60 on 10/25/23 | 254.85 on 10/30/23 | 60.57 on 10/30/23 | 372.50 on 11/01/23 |
| High | 2.3100 on 04/05/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 583.39 on 03/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 214,270 | 212,946,784 | 133,754,872 | 53,691,884 | 40,803,600 |
| Shares Outstanding, K | 125,304 | 381,714 | 354,449 | 601,927 | 83,054 |
| Annual Sales | 0 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 3,660,950,000 |
| Annual Net Income | -30,090,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 845,040,000 |
| Last Quarter Sales | 0 | 10,886,000,000 | 1,928,300,000 | 1,534,100,000 | 901,600,000 |
| Last Quarter Net Income | -7,750,000 | 1,630,000,000 | 606,200,000 | 369,900,000 | 194,520,000 |
| 60-Month Beta | 1.19 | 0.80 | 1.36 | 1.05 | 1.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 04/01/24 | 5.67 on 01/31/24 | 1.60 on 01/23/24 | 0.64 on 02/06/24 | 2.32 on 02/05/24 |
| Latest Earnings Date | 05/20/24 | 04/24/24 | 04/18/24 | 04/25/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 26.24 | 85.13 | 35.97 | 49.43 |